secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001021771-24-000025
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative to present Phase 2 BRTX-100 data at ORS meeting, host webcast Feb 5
--------------------------------------------------------------------------------

- Preliminary 26-52 week blinded data from Phase 2 trial of BRTX-100 for chronic lumbar disc disease to be presented at ORS 2024 Annual Meeting Feb 2-6 in Long Beach.
- Company will host a webcast conference call with slide presentation on Feb 5, 2024 at 8:30 a.m. ET to review the poster.
- No specific efficacy or safety results were disclosed in the press release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000025/0001021771-24-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177124000025/bio8k2124.htm
  HTML page:      https://secwatch.observer/filing/0001021771-24-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer